Compare DMRA & UAMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DMRA | UAMY |
|---|---|---|
| Founded | 2011 | 1968 |
| Country | United States | United States |
| Employees | 7 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.4B |
| IPO Year | 2020 | 1997 |
| Metric | DMRA | UAMY |
|---|---|---|
| Price | $24.60 | $8.63 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | ★ $43.00 | $9.44 |
| AVG Volume (30 Days) | 279.5K | ★ 13.0M |
| Earning Date | 05-11-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $39,257,708.00 |
| Revenue This Year | N/A | $219.89 |
| Revenue Next Year | N/A | $104.28 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 162.80 |
| 52 Week Low | $16.50 | $1.94 |
| 52 Week High | $28.76 | $19.71 |
| Indicator | DMRA | UAMY |
|---|---|---|
| Relative Strength Index (RSI) | 48.32 | 40.05 |
| Support Level | $22.71 | $7.48 |
| Resistance Level | $28.00 | $11.61 |
| Average True Range (ATR) | 1.84 | 1.30 |
| MACD | -0.13 | -0.32 |
| Stochastic Oscillator | 52.01 | 3.95 |
Damora Therapeutics Inc is a biotechnology company that aims to fundamentally redefine care for people with hematologic disorders. The group is advancing a new generation of biologics to treat mutant calreticulin-driven myeloproliferative neoplasms, including essential thrombocythemia and myelofibrosis, where there is cruicial medical need for disease-modifying treatments. Its goal is to rapidly bring forward optimized therapies with broad mutation coverage and exceptional convenience to dramatically improve patient outcomes. The group's pipeline products are DMR-001, DMR-002, DMR-003, and GB3226.
United States Antimony Corp is a fully integrated mining, transportation, milling, smelting, and selling company. It has two operating segments: antimony and zeolite. Its products and services include antimony; silver; gold; zeolite products; and storage, handling, & packaging services. The company's geographical segments are the Domestic, Canada, and Mexico, of which the vast majority of its revenue comes from the Domestic.